Risk of congestive heart failure in an elderly population treated with peripheral alpha-1 antagonists.
Bryson
Chris L
CL
VA Puget Sound Health Services Research and Development, VAMC, Seattle, Washington 98108, USA. cbryson@u.washington.edu
Smith
Nicholas L
NL
Kuller
Lewis H
LH
Chaves
Paulo H M
PH
Manolio
Teri A
TA
Lewis
William
W
Boyko
Edward J
EJ
Furberg
Curt D
CD
Psaty
Bruce M
BM
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects*; D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001581:Benzothiadiazines; D001794:Blood Pressure / Q000187:drug effects; D015331:Cohort Studies; D004232:Diuretics; D005260:Female; D006333:Heart Failure / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D012307:Risk Factors; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects*; D014481:United States / Q000453:epidemiology
D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors